Related references
Note: Only part of the references are listed.Para-(benzoyl)-phenylalanine as a potential inhibitor against LpxC of Leptospira spp.: homology modeling, docking, and molecular dynamics study
Dibyabhaba Pradhan et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2014)
Modern 2D QSAR for drug discovery
Richard A. Lewis et al.
WILEY INTERDISCIPLINARY REVIEWS-COMPUTATIONAL MOLECULAR SCIENCE (2014)
Discovery of novel benzo[b][1,4]oxazin-3(4H)-ones as poly(ADP-ribose)polymerase inhibitors
Anthony R. Gangloff et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2013)
The Role of 3D Pharmacophore Mapping Based Virtual Screening for Identification of Novel Anticancer Agents: An Overview
Amit K. Halder et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2013)
PARP inhibitors in cancer therapy: an update
Gianluca Papeo et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2013)
Kernel-Based Partial Least Squares: Application to Fingerprint-Based QSAR with Model Visualization
Yuling An et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2013)
Design, Synthesis, and Biological Evaluation of a Series of Benzo[de][1,7]naphthyridin-7(8H)-ones Bearing a Functionalized Longer Chain Appendage as Novel PARP1 Inhibitors
Na Ye et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Exploring QSAR and pharmacophore mapping of structurally diverse selective matrix metalloproteinase-2 inhibitors
Amit Kumar Halder et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2013)
Extra precision docking, free energy calculation and molecular dynamics simulation studies of CDK2 inhibitors
Sunil Kumar Tripathi et al.
JOURNAL OF THEORETICAL BIOLOGY (2013)
Exploration of structural and physicochemical requirements and search of virtual hits for aminopeptidase N inhibitors
Amit K. Halder et al.
MOLECULAR DIVERSITY (2013)
PARP inhibitors bounce back
Ken Garber
NATURE REVIEWS DRUG DISCOVERY (2013)
Exploring structural requirements of aurone derivatives as antimalarials by validated DFT-based QSAR, HQSAR, and COMFA-COMSIA approach
Nilanjan Adhikari et al.
MEDICINAL CHEMISTRY RESEARCH (2013)
Failure of Iniparib to Inhibit Poly(ADP-Ribose) Polymerase In Vitro
Anand G. Patel et al.
CLINICAL CANCER RESEARCH (2012)
Role of PARP Inhibitors in Cancer Biology and Therapy
D. Davar et al.
CURRENT MEDICINAL CHEMISTRY (2012)
Molecular Dynamics Simulation, Free Energy Calcuiation and Structure-Based 3D-QSAR Studies of B-RAF Kinase Inhibitors
Ying Yang et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2011)
Chemometric modeling and pharmacophore mapping in coronary heart disease: 2-arylbenzoxazoles as cholesteryl ester transfer protein inhibitors
Dhritiman Jana et al.
MEDCHEMCOMM (2011)
Validated predictive QSAR modeling of N-aryl-oxazolidinone-5-carboxamides for anti-HIV protease activity
Amit Kumar Halder et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
Development of substituted 6-[4-fluoro-3-(piperazin-1-ylcarbonyl)benzyl]-4,5-dimethylpyridazin-3(2H)-ones as potent poly(ADP-ribose) polymerase-1 (PARP-1) inhibitors active in BRCA deficient cells
Federica Ferrigno et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
Discovery and SAR of substituted 3-oxoisoindoline-4-carboxamides as potent inhibitors of poly(ADP-ribose) polymerase (PARP) for the treatment of cancer
Viraj B. Gandhi et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
Discovery and SAR of novel, potent and selective hexahydrobenzonaphthyridinone inhibitors of poly(ADP-ribose)polymerase-1 (PARP-1)
Caterina Torrisi et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
Synthesis and biological evaluation of substituted 2-phenyl-2H-indazole-7-carboxamides as potent poly(ADP-ribose) polymerase (PARP) inhibitors
Rita Scarpelli et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
Identification and SAR of novel pyrrolo[1,2-a]pyrazin-1(2H)-one derivatives as inhibitors of poly(ADP-ribose) polymerase-1 (PARP-1)
Giovanna Pescatore et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
Structural Findings of 2-Phenylindole-3-Carbaldehyde Derivatives for Antimitotic Activity by FA-sMLR QSAR Analysis
Amit K. Halder et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2010)
Chemometric modeling, docking and in silico design of triazolopyrimidine-based dihydroorotate dehydrogenase inhibitors as antimalarials
Probir Kumar Ojha et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2010)
Optimization of Phenyl-Substituted Benzimidazole Carboxamide Poly(ADP-Ribose) Polymerase Inhibitors: Identification of (S)-2-(2-Fluoro-4-(pyrrolidin-2-yl)pheny)-1H-benzimidazole-4-carboxamide (A-966492), a Highly Potent and Efficacious Inhibitor
Thomas D. Penning et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Identification of aminoethyl pyrrolo dihydroisoquinolinones as novel poly(ADP-ribose) polymerase-1 inhibitors
Danila Branca et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
Identification of substituted pyrazolo[1,5-a]quinazolin-5(4H)-one as potent poly(ADP-ribose)polymerase-1 (PARP-1) inhibitors
Federica Orvieto et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
Prediction of Potency of Protease Inhibitors Using Free Energy Simulations with Polarizable Quantum Mechanics-Based Ligand Charges and a Hybrid Water Model
Debananda Das et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2009)
Discovery of 2-{4-[(3S)-Piperidin-3-yl]phenyl}-2H-indazole-7-carboxamide (MK-4827): A Novel Oral Poly(ADP-ribose)polymerase (PARP) Inhibitor Efficacious in BRCA-1 and-2 Mutant Tumors
Philip Jones et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Synthesis and SAR of novel, potent and orally bioavailable benzimidazole inhibitors of poly(ADP-ribose) polymerase (PARP) with a quaternary methylene-amino substituent
Gui-Dong Zhu et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)
Poly(ADP-ribose) polymerase as a drug target for cardiovascular disease and cancer:: An update
Eszter M. Horvath et al.
DRUG NEWS & PERSPECTIVES (2007)
Benchmarking sets for molecular docking
Niu Huang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
PHASE: a new engine for pharmacophore perception, 3D QSAR model development, and 3D database screening: 1. Methodology and preliminary results
Steven L. Dixon et al.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2006)
Deficiency in the repair of DNA damage by homologous recombination and sensitivity to poly(ADP-ribose) polymerase inhibition
Nuala McCabe et al.
CANCER RESEARCH (2006)
Accurate prediction of the relative potencies of members of a series of kinase inhibitors using molecular docking and MM-GBSA scoring
Paul D. Lyne et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Virtual screening workflow development guided by the receiver operating characteristic curve approach. Application to high-throughput docking on metabotropic glutamate receptor subtype 4
N Triballeau et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Glide: A new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy
RA Friesner et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Glide: A new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening
TA Halgren et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
PARP-1, PARP-2 and ATM in the DNA damage response: functional synergy in mouse development
A Huber et al.
DNA REPAIR (2004)
Guidelines for developing and using quantitative structure-activity relationships
JD Walker et al.
ENVIRONMENTAL TOXICOLOGY AND CHEMISTRY (2003)
Methods for reliability and uncertainty assessment and for applicability evaluations of classification- and regression-based QSARs
L Eriksson et al.
ENVIRONMENTAL HEALTH PERSPECTIVES (2003)
Potential clinical applications of poly(ADP-ribose) polymerase (PARP) inhibitors
L Tentori et al.
PHARMACOLOGICAL RESEARCH (2002)
Beware of q(2)!
A Golbraikh et al.
JOURNAL OF MOLECULAR GRAPHICS & MODELLING (2002)
Modeling of poly(ADP-ribose)polymerase (PARP) inhibitors. Docking of ligands and quantitative structure-activity relationship analysis
G Costantino et al.
JOURNAL OF MEDICINAL CHEMISTRY (2001)
The Protein Data Bank
HM Berman et al.
NUCLEIC ACIDS RESEARCH (2000)
Share Paper
